
Oral PCSK9 Inhibitor, Role of Neurology Department Chairs, Anti-IgLON5 Disease
2026-09-17
0:00
5:02
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the first oral PCSK9 inhibitor, the transforming role of the neurology department chair, and anti-IgLON5 disease.
Fler avsnitt från "Neurology Today in 5"



Missa inte ett avsnitt av “Neurology Today in 5” och prenumerera på det i GetPodcast-appen.








